Home
About
Overview
Management
Board of Directors
Careers
Pipeline
Overview
Metabolic Disease Programs
VK2735 (Obesity, Metabolic Disorders)
VK2809 (NASH/MASH)
Rare Disease Program
VK0214 (X-ALD)
Other Pipeline Programs
VK5211 (Hip Fracture, Muscle Wasting)
VK0612 (Type 2 Diabetes)
VK1430 (Hypertriglyceridemia, NASH)
EPOR Agonist Program (Anemia)
Investors & Media
Overview
Stock Information
News & Events
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder Services
Corporate Presentation
Contact
Archive for the “Clinical” Category
Not Found
Sorry, but the requested resource was not found on this site.
Home
About
Overview
Management
Board of Directors
Careers
Pipeline
Overview
Metabolic Disease Programs
VK2735 (Obesity, Metabolic Disorders)
VK2809 (NASH/MASH)
Rare Disease Program
VK0214 (X-ALD)
Other Pipeline Programs
VK5211 (Hip Fracture, Muscle Wasting)
VK0612 (Type 2 Diabetes)
VK1430 (Hypertriglyceridemia, NASH)
EPOR Agonist Program (Anemia)
Investors & Media
Overview
Stock Information
News & Events
SEC Filings
Analyst Coverage
Corporate Governance
Shareholder Services
Corporate Presentation
Contact
